A 10-year-long ongoing complete response to vismodegib as first-line treatment in adult metastatic medulloblastoma. [PDF]
Acta OncolAbdi S +5 more
europepmc +1 more source
Efficacy and safety of Ruxolitinib-based combination therapy in the patients with Myelofibrosis (MF): a systematic review and meta-analysis. [PDF]
Ann MedTan S, Li Y, Cao Y, Sun W, Hui W.
europepmc +1 more source
Ring expansion of bicyclo[1.1.0]butyl ketones to bicyclo[2.1.1]hexenes using ketone as both activating and reacting groups. [PDF]
Nat CommunGe J +8 more
europepmc +1 more source
Successful remission of advanced basosquamous cell carcinoma with cemiplimab monotherapy. [PDF]
JAAD Case RepGager D, Anderson B, Drabick J.
europepmc +1 more source
Transcriptomic profiling reveals the role of Hedgehog signaling as a biomarker and in the pathogenesis of Ménétrier's disease. [PDF]
J PatholShin M +7 more
europepmc +1 more source
Low-dose oral minoxidil for the management of vismodegib-induced alopecia. [PDF]
JAAD Case RepNewcomer J, Aghazadeh N.
europepmc +1 more source
Variance in state Medicaid coverage of hedgehog pathway inhibitors in the treatment of basal cell carcinoma. [PDF]
Proc (Bayl Univ Med Cent)Arora N, Skaggs E, Bicknell L.
europepmc +1 more source
Advanced Basal Cell Carcinoma in a Geriatric Patient: A Case Report and Ethical Considerations. [PDF]
CureusVelázquez Arenas L +2 more
europepmc +1 more source
New drug: Sonidegib for basal cell carcinoma [PDF]
Australian Prescriber, 2018 openaire +1 more source
Treatment of Basosquamous Carcinoma With Sonidegib in a Patient with HIV
Actas Dermo-SifiliográficasC. Fernández Romero +3 more
openaire +2 more sources